Hypermelanosis due to endocrine disorder (Q89733): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(3 intermediate revisions by the same user not shown)
Property / Canary Token
 
dki-india-ID_1908185920
Property / Canary Token: dki-india-ID_1908185920 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 16:33, 15 August 2026

Diffuse hypermelanosis due to secretion of abnormal amounts of melanocyte stimulating hormones including beta MSH and ACTH. This may be seen with pituitary tumours (e.g. pituitary Cushing syndrome) or following adrenal failure (Addison disease) or adrenalectomy (Nelson syndrome). More rarely it may be seen with acromegaly and with hyperthyroidism.
Language Label Description Also known as
default for all languages
ID_1908185920
    English
    Hypermelanosis due to endocrine disorder
    Diffuse hypermelanosis due to secretion of abnormal amounts of melanocyte stimulating hormones including beta MSH and ACTH. This may be seen with pituitary tumours (e.g. pituitary Cushing syndrome) or following adrenal failure (Addison disease) or adrenalectomy (Nelson syndrome). More rarely it may be seen with acromegaly and with hyperthyroidism.

      Statements

      CID11:ID_1908185920
      0 references
      dki-india-ID_1908185920
      0 references
      Concluído
      0 references
      13 August 2026
      0 references